METHYLGENE INC. and MIRATI THERAPEUTICS, INC. ARRANGEMENT AGREEMENT May 8, 2013Arrangement Agreement • June 14th, 2013 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • Ontario
WHEREAS each of the Company and Mirati, a wholly-owned subsidiary of the Company, have agreed to proceed with a corporate restructuring by way of an arrangement under the provisions of the CBCA whereby, upon completion of the Arrangement, the Shareholders will exchange their Common Shares for Mirati Shares, resulting in, among other things, the Shareholders owning a proportionate interest in Mirati and the Company becoming a wholly-owned subsidiary of Mirati;
